previou
studi
report
clinic
use
revers
transcriptionpolymeras
chain
reaction
rtpcr
detect
thyroglobulin
tg
mrna
peripher
blood
patient
differenti
thyroid
carcinoma
evalu
use
measur
tg
mrna
peripher
blood
patient
diagnos
thyroid
carcinoma
total
thyroidectomi
realtim
quantit
rtpcr
use
dehydrogenas
gapdh
mrna
intern
control
surprisingli
detect
tg
mrna
sampl
obtain
total
thyroidectomi
includ
medullari
carcinoma
statist
differ
express
level
tg
mrna
patient
without
metastasi
signific
correl
found
serum
tg
concentr
express
level
tg
mrna
result
give
rise
question
regard
clinic
applic
rtpcr
detect
also
quantit
measur
tg
mrna
peripher
blood
thyroid
carcinoma
often
recur
mani
year
surgeri
loh
et
al
monitor
serum
thyroglobulin
tg
immunoassay
use
detect
residu
recurr
differenti
thyroid
carcinoma
dtc
total
thyroidectomi
howev
use
method
limit
requir
thyroid
hormon
withdraw
attain
optim
sensit
interfer
antithyroglobulin
antibodi
singer
et
al
recent
report
demonstr
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
detect
circul
cancer
cell
peripher
blood
patient
malign
prostat
cancer
ghossein
et
al
neuroblastoma
mattano
et
al
sensit
rtpcr
assay
amplifi
thyroidspecif
mrna
tg
thyroid
peroxidas
tpo
may
util
earli
detect
dtc
recurr
thu
may
import
therapeut
prognost
implic
fact
recent
report
shown
clinic
use
rtpcr
detect
tg
tpo
ret
ptc
followup
dtc
ringel
et
al
tallini
et
al
exampl
tg
mrna
peripher
blood
becam
detect
earlier
serum
tg
case
recurr
thyroid
papillari
carcinoma
recent
ringel
et
al
report
clinic
use
realtim
quantit
measur
tg
mrna
peripher
blood
patient
dtc
report
howev
use
appropri
intern
refer
dehydrogenas
gapdh
mrna
encourag
optimist
report
appli
method
patient
followup
dtc
howev
found
tg
tpo
mrna
detect
peripher
blood
patient
test
result
differ
report
previous
therefor
felt
need
reevalu
tg
mrna
detect
one
problem
previou
studi
express
level
tg
mrna
calcul
conjunct
use
appropri
intern
control
result
simpl
rtpcr
detect
vari
respons
subtl
chang
condit
patient
undergon
total
thyroidectomi
constitut
good
model
case
evalu
problem
measur
tg
mrna
peripher
blood
patient
total
thyroidectomi
determin
express
level
tg
mrna
real
timequantit
rtpcr
use
gapdh
mrna
intern
control
evalu
patient
male
femal
year
age
papillari
follicular
medullari
carcinoma
underw
total
thyroidectomi
blood
drawn
least
month
surgeri
administr
radioact
iodin
dtc
patient
evid
metastas
lung
bone
mediastinum
lung
bone
detect
either
comput
tomographi
scintigram
patient
metastasi
patient
without
metastasi
receiv
mean
mci
mean
mci
respect
patient
total
thyroidectomi
except
medullari
carcinoma
receiv
suppress
dose
thyroxin
serum
thyroid
stimul
hormon
tsh
level
undetect
healthi
subject
male
femal
year
age
evid
thyroid
diseas
also
examin
control
protocol
approv
institut
review
board
particip
institut
inform
consent
obtain
peripher
blood
collect
heparin
tube
ml
sampl
place
immedi
ice
next
ml
dextran
wako
osaka
japan
ad
tube
place
ice
min
supernat
collect
centrifug
precipit
dispers
distil
water
lyse
remain
erythrocyt
equal
volum
nacl
immedi
ad
isol
cell
wash
centrifug
total
rna
extract
follow
standard
procedur
chomczynski
sacchi
resolv
distil
water
store
total
rna
revers
transcrib
rt
mixtur
contain
mm
trishcl
ph
mm
kcl
mm
dithiothreitol
mm
mgcl
mm
deoxynucleotid
triphosph
dntp
u
mmlv
revers
transcriptas
gibco
gaithersburg
md
u
rnase
inhibitor
takara
shiga
japan
random
hexam
takara
total
volum
min
firststrand
cdna
use
templat
pcr
reaction
specif
primer
tg
cdna
previous
describ
tallini
et
al
reaction
mixtur
consist
cdna
primer
ex
taq
buffer
mm
dntp
mix
u
ex
taq
polymeras
nucleasefre
water
final
volum
ex
taq
buffer
dntp
mix
ex
taq
polymeras
obtain
takara
reaction
mixtur
subject
cycl
denatur
min
anneal
min
extens
min
pcr
amplif
reaction
mixtur
run
seakem
gtg
agaros
gel
takara
gel
stain
ethidium
bromid
sampl
without
revers
transcript
use
neg
control
realtim
quantit
rtpcr
taqman
pcr
tg
gapdh
mrna
use
abi
prism
sequenc
detect
system
taqman
pcr
core
reagent
kit
pe
biosystem
foster
citi
ca
perform
previous
describ
takano
et
al
primer
use
amplif
tg
cdna
chang
set
primer
use
report
tallini
et
al
probe
tg
cdna
use
taqman
pcr
cdna
use
measur
copi
number
condit
taqman
pcr
follow
min
follow
cycl
second
min
recombin
pgem
tvector
promega
tokyo
japan
contain
tg
gapdh
cdna
construct
pcr
clone
set
primer
use
taqman
pcr
use
standard
sampl
express
level
tg
mrna
calcul
divid
copi
number
tg
mrna
gapdh
mrna
intraassay
variabl
ng
l
thyroid
total
rna
respect
interassay
variabl
across
period
ngl
thyroid
total
rna
respect
portion
normal
thyroid
tissu
opposit
lobe
thyroid
papillari
carcinoma
obtain
surgeri
total
rna
extract
follow
standard
procedur
serum
tg
measur
use
commerci
radioimmunoassay
kit
abbead
thyroglobulin
eiken
tokyo
japan
intrassay
variabl
l
interassay
variabl
across
period
l
respect
assay
sensit
determin
interassay
coeffici
variat
cv
l
cut
level
kit
l
serum
antitg
antibodi
detect
semiquantit
microtitr
particl
agglutin
test
vitro
diagnost
detect
titrat
antitg
antibodi
human
serum
serodiaatg
fujirebio
tokyo
japan
statist
analysi
differ
group
carri
use
mannwhitney
u
test
linear
correl
analysi
use
examin
correl
serum
tg
express
level
tg
mrna
peripher
blood
ps
consid
signific
tg
mrna
detect
sampl
test
includ
sampl
patient
diagnos
medullari
carcinoma
repres
data
shown
figur
reliabl
quantit
rtpcr
estim
ad
total
rna
normal
thyroid
ml
blood
healthi
subject
tggapdh
mrna
ratio
sampl
without
addit
thyroid
rna
thyroid
rna
increas
ng
per
l
blood
per
l
blood
linear
increas
tggapdh
mrna
ratio
observ
indic
reliabl
quantit
measur
figur
result
use
construct
standard
curv
follow
experi
use
method
express
level
tg
mrna
peripher
blood
patient
healthi
subject
calcul
sampl
success
measur
realtim
quantit
rtpcr
confirm
express
tg
mrna
sampl
statist
differ
patient
without
metastasi
figur
serum
tg
measur
dtc
patient
without
serum
antitg
antibodi
set
result
compar
figur
statist
differ
tg
mrna
level
observ
serum
tg
detect
patient
metastasi
undetect
patient
without
metastasi
serum
tg
undetect
patient
diagnos
medullari
carcinoma
quantit
measur
tg
mrna
possibl
figur
result
suggest
serum
tg
superior
marker
distant
metastasi
dtc
tg
mrna
peripher
blood
correl
tg
mrna
serum
tg
estim
patient
correl
observ
two
figur
vast
major
thyroid
carcinoma
differenti
tumour
origin
follicular
epithelium
show
total
rna
normal
thyroid
ad
ml
blood
healthi
subject
realtim
quantit
rtpcr
describ
method
carri
copi
number
gapdh
mrna
simultan
measur
express
level
tg
mrna
calcul
ratio
tg
gapdh
mrna
result
shown
mean
triplic
determin
either
follicular
papillari
structur
serum
tg
immunodetect
measur
current
best
avail
indic
tumour
metastas
even
though
diagnost
use
sever
limit
circul
tumour
cell
detect
sensit
pcr
amplif
tumourspecif
abnorm
gene
sequenc
detect
tissuespecif
abnorm
gene
transcript
normal
absent
peripher
blood
thyroid
tumour
repres
ideal
target
studi
activ
express
tissuespecif
marker
tg
tpo
despit
promis
report
detect
tg
mrna
peripher
blood
preliminari
studi
show
tg
transcript
detect
sampl
test
includ
one
healthi
subject
recent
studi
suggest
limit
clinic
applic
method
report
wingo
et
al
detect
tg
transcript
peripher
blood
healthi
subject
measur
realtim
quantit
rtpcr
wingo
et
al
bojunga
et
al
found
tg
mrna
express
specif
thyroid
tissu
correl
diagnosi
thyroid
cancer
patient
recommend
examin
method
quantit
measur
bojunga
et
al
therefor
decid
reevalu
method
use
sampl
obtain
patient
total
thyroidectomi
tg
transcript
circul
thyroid
cell
normal
thyroid
may
neglig
detect
tg
transcript
sampl
test
even
patient
diagnos
medullari
carcinoma
circul
thyroid
follicular
cell
like
occur
realtim
quantit
rtpcr
assay
confirm
express
tg
mrna
sampl
increas
fluoresc
signal
hybrid
tg
cdnaspecif
probe
observ
realtim
quantit
rtpcr
high
level
tg
mrna
express
patient
without
evid
metastasi
exampl
one
patient
copi
number
tg
mrna
ml
peripher
blood
compar
pg
total
rna
normal
thyroid
tissu
approxim
equal
thyroid
cell
hard
believ
mani
thyroid
cell
still
circul
peripher
blood
patient
thyroidectomi
without
evid
distant
metastasi
could
sourc
circul
cell
tsh
receptor
mrna
previous
consid
express
thyroid
found
express
adipocyt
lymphocyt
franci
et
al
endo
et
al
tg
mrna
detect
studi
thu
might
deriv
thyroid
cell
instead
like
lymphocyt
express
small
quantiti
tg
mrna
known
express
variou
kind
mrna
alphafetoprotein
afp
carcinoembryon
antigen
cea
lafargefrayssinet
et
al
couteli
et
al
use
consid
tumourspecif
express
tg
mrna
like
limit
thyroid
follicular
cell
recent
found
express
cell
line
deriv
lung
gastric
carcinoma
data
shown
possibl
regul
tg
mrna
express
lymphocyt
control
unknown
factor
detect
tg
mrna
like
becom
altern
mean
achiev
earli
detect
recurr
thyroid
carcinoma
sensit
detect
recurr
would
interf
basal
express
tg
mrna
peripher
blood
therefor
seem
like
diagnost
method
present
tallini
ringel
may
use
limit
popul
patient
consider
number
thyroid
tumour
cell
express
high
copi
number
tg
mrna
circul
fact
result
show
statist
differ
sampl
patient
without
distant
metastasi
obtain
evid
method
superior
convent
measur
serum
tg
hard
util
tg
mrna
data
differenti
patient
metastasi
without
wherea
serum
tg
measur
show
l
patient
distant
metastasi
high
valu
interassay
cv
quantit
measur
tg
mrna
disadvantag
followup
patient
long
period
moreov
tg
mrna
serum
tg
measur
sampl
show
signific
correl
result
suggest
sourc
tg
mrna
serum
tg
might
differ
discuss
former
might
deriv
thyroid
follicular
cell
use
tpo
mrna
detect
thyroid
carcinoma
also
report
conjunct
studi
howev
preliminari
data
show
tpo
mrna
detect
rtpcr
sampl
test
includ
healthi
subject
patient
total
thyroidectomi
without
distant
metastasi
data
shown
consid
tpo
mrna
usual
less
abund
tg
mrna
thyroid
cell
like
use
tpo
mrna
instead
tg
would
improv
clinic
use
method
summari
found
advantag
diagnos
dtc
quantit
measur
tg
mrna
peripher
blood
consid
intens
reevalu
includ
determin
percentag
tg
mrna
deriv
thyroid
follicular
cancer
cell
necessari
regard
method
consid
clinic
applic
work
support
grantinaid
encourag
young
scientist
tt
ministri
educ
scienc
sport
cultur
japan
